|
| |
| Drug Development |
|
ReceptoPharm is developing proprietary
therapeutic protein products for the treatment of neurological,
viral and and autoimmune disorders. |
| »
Learn More |
|
|
| |
| CRO Services |
ReceptoPharm offers a full range of contract
research services catering to small and start-up biotech companies. |
| » Learn More |
|
|
|
Below you will find the most recent ReceptoPharm
press releases. To view press releases from
previous years, please visit the Archives.
November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program
October 26, 2010
Nutra Pharma Selects Nutritional Alliance as its Global Sales Agent
September 27, 2010
Nutra Pharma Introduces Nyloxin for Pets - a Treatment for Moderate to Severe Chronic Pain in Companion Animals
September 14, 2010
Nutra Pharma Amends Cobroxin Distribution Agreement with XenaCare Holdings
August 19, 2010
Nutra Pharma Begins Drug Registration Process in India for Nyloxin - a Treatment for Moderate to Severe Chronic Pain
August 09, 2010
Nutra Pharma Announces Amarey Nova Medical as its Exclusive Nyloxin Distributor in Colombia
August 06, 2010
Nutra Pharma Announces Second Quarter 2010 Sales and Distribution Update
July 28, 2010
Nutra Pharma Receives Patent for Novel Antiviral Treatment using Modified Cobra Venom
July 22, 2010
Nutra Pharma Drug Discovery Subsidiary to Introduce Novel Antiviral Therapy at the International AIDS Conference in Vienna, Austria
June 23, 2010
Nutra Pharma Begins Drug Registration Process in Central America for its Nyloxin Pain Reliever
|
|
|
|
| |
| E-Alerts
|
| Signup to receive news and announcements
from ReceptoPharm and Nutra Pharma: |
|
|
|
|
|
|
|
